IC
CME icon

Inscription Capital’s CME Group CME Stock Holding History

Inscription Capital’s Portfolio CME Stock Details CME Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$520K Buy
2,353
+253
+12% +$70K 0.05% 379
2026
Q1 		$620K Buy
2,100
+34
+2% +$10.1K 0.07% 304
2025
Q4 		$564K Buy
2,066
+26
+1% +$7.07K 0.06% 327
2025
Q3 		$551K Buy
2,040
+52
+3% +$14.1K 0.06% 327
2025
Q2 		$548K Sell
1,988
-236
-11% -$64.2K 0.08% 190
2025
Q1 		$479K Buy
+2,224
New +$549K 0.08% 180
2024
Q3 		$457K Sell
2,073
-104
-5% -$21.5K 0.07% 203
2024
Q2 		$428K Sell
2,177
-47
-2% -$9.71K 0.07% 196
2024
Q1 		$479K Buy
2,224
+380
+21% +$79.8K 0.08% 180
2023
Q4 		$388K Buy
+1,844
New +$393K 0.11% 141
2022
Q1 		– Sell
-2,018
Closed -$468K – 199
2021
Q4 		$468K Buy
2,018
+15
+0.7% +$3.3K 0.13% 143
2021
Q3 		$387K Sell
2,003
-1,172
-37% -$237K 0.12% 146
2021
Q2 		$675K Buy
+3,175
New +$670K 0.08% 172
2019
Q2 		– Sell
-476
Closed -$78K – 129
2019
Q1 		$78K Sell
476
-179
-27% -$31.6K 0.04% 176
2018
Q4 		$123K Buy
+655
New +$121K 0.07% 154

Other funds holding CME

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Sanders Capital
Sanders Capital West Palm Beach, Florida $99.8B AUM 47.9% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM

Inscription Capital's CME Position: Q2 2026 in Review

Inscription Capital increased its CME Group (CME) stake by 12% in Q2 2026, buying an estimated $70K and bringing the position to 2,353 shares worth $520K. The position accounts for 0.05% of the portfolio, ranked #379.

Inscription Capital first reported a position in CME in Q4 2018 and has held it in 15 quarters since. The position peaked at $675K in Q2 2021. 1,698 funds tracked by Wall St. Rank hold CME as of Q2 2026.

  • Inscription Capital held 2,353 shares of CME Group worth $520K as of Q2 2026.
  • Inscription Capital bought 253 CME Group shares in Q2 2026, an estimated $70K.
  • CME Group made up 0.05% of Inscription Capital's portfolio in Q2 2026, its #379 holding.
  • Inscription Capital first reported a position in CME Group in Q4 2018 and has held it in 15 quarters since.
  • Inscription Capital's CME Group position peaked at $675K in Q2 2021.
  • 1,698 funds tracked by Wall St. Rank held CME Group as of Q2 2026.

Based on Inscription Capital's 13F filing for Q2 2026, filed 13 Aug 2026.